Delivery Order SPE2DR25D1053-SPE2DR26FT811
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100-count packages) valued at $1,859.55 with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 units. This non-competitive delivery order, valued at $1,151.19 with a firm fixed price structure, was executed on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.12 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 on July 28, 2025, with completion expected by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,377.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count units), with a completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,826.85 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets (100-count bottles) on October 15, 2025, with completion scheduled for October 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets (100 count) valued at $1,016.28 under a firm fixed price arrangement. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.28 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 units. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive award. Performance of this delivery order will occur at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 tablets, with a ceiling value of $1,131.12. This is a firm fixed price delivery order with an ultimate completion date of November 3, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100, with a ceiling value of $1,687.28. This firm fixed price delivery order, which represents a non-set-aside competitive award, is expected to be completed by August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100 units, with a contract ceiling value of $1,424.16. This is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The award was made through open competition with no...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT811Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in a quantity of 100 units, valued at $1,435.52. This non-compete, firm fixed-price delivery order was awarded on November 12, 2025, with an ultimate completion date of November 13, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements through competitive procurement, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for controlled-substance amphetamine tablets supports the military health system's medical supply needs as part of the broader pharmaceutical support architecture provided through the DLA prime vendor program, which supplies the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/12/25 |